The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Human Albumin Market Research Report 2024
Synopsis
Albumin-based therapies such as Idelvion (CSL654 rIX-FP) by CSL Behring received marketing approval from the US FDA in March 2016 and from the EMA in May 2016. Apart from these, Albutropin (TV-1106) by Teva Pharmaceuticals, Ampion by Ampio Pharmaceuticals, and Albutein by Grifols (for Alzheimer's disease) are expected to enter the market during the forecast period.
The global Human Albumin market was valued at US$ 5132.1 million in 2023 and is anticipated to reach US$ 6954 million by 2030, witnessing a CAGR of 4.5% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Human Albumin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Albumin.
Report Scope
The Human Albumin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Albumin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Albumin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CSL Behring
Grifols
Baxalta
Octapharma
Kedrion
Segment by Type
5% Concentrations
25% Concentrations
Others
Segment by Application
Therapeutics
Drug Formulation & Vaccine
Component of Media
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human Albumin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human Albumin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Albumin-based therapies such as Idelvion (CSL654 rIX-FP) by CSL Behring received marketing approval from the US FDA in March 2016 and from the EMA in May 2016. Apart from these, Albutropin (TV-1106) by Teva Pharmaceuticals, Ampion by Ampio Pharmaceuticals, and Albutein by Grifols (for Alzheimer's disease) are expected to enter the market during the forecast period.
The global Human Albumin market was valued at US$ 5132.1 million in 2023 and is anticipated to reach US$ 6954 million by 2030, witnessing a CAGR of 4.5% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Human Albumin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Albumin.
Report Scope
The Human Albumin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Albumin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Albumin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CSL Behring
Grifols
Baxalta
Octapharma
Kedrion
Segment by Type
5% Concentrations
25% Concentrations
Others
Segment by Application
Therapeutics
Drug Formulation & Vaccine
Component of Media
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human Albumin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human Albumin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Human Albumin Market Overview
1.1 Product Overview and Scope of Human Albumin
1.2 Human Albumin Segment by Type
1.2.1 Global Human Albumin Market Value Comparison by Type (2024-2030)
1.2.2 5% Concentrations
1.2.3 25% Concentrations
1.2.4 Others
1.3 Human Albumin Segment by Application
1.3.1 Global Human Albumin Market Value by Application: (2024-2030)
1.3.2 Therapeutics
1.3.3 Drug Formulation & Vaccine
1.3.4 Component of Media
1.3.5 Others
1.4 Global Human Albumin Market Size Estimates and Forecasts
1.4.1 Global Human Albumin Revenue 2019-2030
1.4.2 Global Human Albumin Sales 2019-2030
1.4.3 Global Human Albumin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Human Albumin Market Competition by Manufacturers
2.1 Global Human Albumin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Human Albumin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Human Albumin Average Price by Manufacturers (2019-2024)
2.4 Global Human Albumin Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Human Albumin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Albumin, Product Type & Application
2.7 Human Albumin Market Competitive Situation and Trends
2.7.1 Human Albumin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Human Albumin Players Market Share by Revenue
2.7.3 Global Human Albumin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Human Albumin Retrospective Market Scenario by Region
3.1 Global Human Albumin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Human Albumin Global Human Albumin Sales by Region: 2019-2030
3.2.1 Global Human Albumin Sales by Region: 2019-2024
3.2.2 Global Human Albumin Sales by Region: 2025-2030
3.3 Global Human Albumin Global Human Albumin Revenue by Region: 2019-2030
3.3.1 Global Human Albumin Revenue by Region: 2019-2024
3.3.2 Global Human Albumin Revenue by Region: 2025-2030
3.4 North America Human Albumin Market Facts & Figures by Country
3.4.1 North America Human Albumin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Human Albumin Sales by Country (2019-2030)
3.4.3 North America Human Albumin Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Human Albumin Market Facts & Figures by Country
3.5.1 Europe Human Albumin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Human Albumin Sales by Country (2019-2030)
3.5.3 Europe Human Albumin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Albumin Market Facts & Figures by Country
3.6.1 Asia Pacific Human Albumin Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Human Albumin Sales by Country (2019-2030)
3.6.3 Asia Pacific Human Albumin Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Human Albumin Market Facts & Figures by Country
3.7.1 Latin America Human Albumin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Human Albumin Sales by Country (2019-2030)
3.7.3 Latin America Human Albumin Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Albumin Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Albumin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Human Albumin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Human Albumin Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Human Albumin Sales by Type (2019-2030)
4.1.1 Global Human Albumin Sales by Type (2019-2024)
4.1.2 Global Human Albumin Sales by Type (2025-2030)
4.1.3 Global Human Albumin Sales Market Share by Type (2019-2030)
4.2 Global Human Albumin Revenue by Type (2019-2030)
4.2.1 Global Human Albumin Revenue by Type (2019-2024)
4.2.2 Global Human Albumin Revenue by Type (2025-2030)
4.2.3 Global Human Albumin Revenue Market Share by Type (2019-2030)
4.3 Global Human Albumin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Human Albumin Sales by Application (2019-2030)
5.1.1 Global Human Albumin Sales by Application (2019-2024)
5.1.2 Global Human Albumin Sales by Application (2025-2030)
5.1.3 Global Human Albumin Sales Market Share by Application (2019-2030)
5.2 Global Human Albumin Revenue by Application (2019-2030)
5.2.1 Global Human Albumin Revenue by Application (2019-2024)
5.2.2 Global Human Albumin Revenue by Application (2025-2030)
5.2.3 Global Human Albumin Revenue Market Share by Application (2019-2030)
5.3 Global Human Albumin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 CSL Behring
6.1.1 CSL Behring Corporation Information
6.1.2 CSL Behring Description and Business Overview
6.1.3 CSL Behring Human Albumin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 CSL Behring Human Albumin Product Portfolio
6.1.5 CSL Behring Recent Developments/Updates
6.2 Grifols
6.2.1 Grifols Corporation Information
6.2.2 Grifols Description and Business Overview
6.2.3 Grifols Human Albumin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Grifols Human Albumin Product Portfolio
6.2.5 Grifols Recent Developments/Updates
6.3 Baxalta
6.3.1 Baxalta Corporation Information
6.3.2 Baxalta Description and Business Overview
6.3.3 Baxalta Human Albumin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Baxalta Human Albumin Product Portfolio
6.3.5 Baxalta Recent Developments/Updates
6.4 Octapharma
6.4.1 Octapharma Corporation Information
6.4.2 Octapharma Description and Business Overview
6.4.3 Octapharma Human Albumin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Octapharma Human Albumin Product Portfolio
6.4.5 Octapharma Recent Developments/Updates
6.5 Kedrion
6.5.1 Kedrion Corporation Information
6.5.2 Kedrion Description and Business Overview
6.5.3 Kedrion Human Albumin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Kedrion Human Albumin Product Portfolio
6.5.5 Kedrion Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Albumin Industry Chain Analysis
7.2 Human Albumin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Albumin Production Mode & Process
7.4 Human Albumin Sales and Marketing
7.4.1 Human Albumin Sales Channels
7.4.2 Human Albumin Distributors
7.5 Human Albumin Customers
8 Human Albumin Market Dynamics
8.1 Human Albumin Industry Trends
8.2 Human Albumin Market Drivers
8.3 Human Albumin Market Challenges
8.4 Human Albumin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
